Press Releases

WASHINGTON —House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is investigating the Food and Drug Administration’s (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Chairman Comer raises concern that the agency’s failure to regulate CBD products could allow dangerous products to come to market and is requesting documents and information to enable ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) is requesting the appearance of Dr. Susan Mayne, Director of the Center for Food Safety and Applied Nutrition at the U.S. Food and Drug Administration (FDA) since 2015, for a transcribed interview to assist in an investigation of the FDA’s response to the 2022 infant formula shortage. “Former FDA officials have confirmed dysfunction at the FDA created and exacerbated a ...

WASHINGTON—Subcommittee on Cybersecurity, Information Technology, and Government Innovation Chairwoman Nancy Mace (R-S.C.), Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.), and Subcommittee on Government Operations and the Federal Workforce Chairman Pete Sessions (R-Texas) are pressing the Office of Management and Budget (OMB) for information on the Biden Administration’s implementation of a law designed to help federal agencies determine what work ...

WASHINGTON—House Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) delivered opening remarks at today’s subcommittee hearing titled “FDA Oversight Part 1: The Infant Formula Shortage” to conduct oversight of the FDA’s response to the nationwide infant formula shortage.

WASHINGTON—The House Committee on Oversight and Accountability Subcommittee on Health Care and Financial Services held a hearing today titled “FDA Oversight Part 1: The Infant Formula Shortage.” At the hearing, subcommittee members asked Frank Yiannas, Former Deputy Commissioner of the Food and Drug Administration (FDA) about the FDA’s failure to respond to the infant formula crisis. ...

WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is conducting oversight of the Food and Drug Administration’s (FDA) regulation of tobacco and nicotine products through its Center for Tobacco Products (CTP). The CTP has failed to effectively define and administer its tobacco and nicotine regulatory programs, resulting in industry uncertainty and unsafe products reaching the marketplace. In a letter to Commissioner Robert Califf of the Food and Drug ...

Renew request for communications between FDA, HHS, and White House staff WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) are calling on the U.S. Food and Drug Administration (FDA) to provide documents and communications related to the FDA’s response to the United States’ infant formula crisis, reiterating serious concerns over the Biden ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) will hold a hearing titled “FDA Oversight Part I: The Infant Formula Shortage” to investigate the U.S. Food and Drug Administration’s (FDA) response to the infant formula crisis, including the FDA’s failure to heed watchdog warnings about a bacteria outbreak in a formula production ...

Republicans Bring Oversight to the Inflation Crisis, Seek Solutions to Help the Economy Recover WASHINGTON – The House Committee on Oversight and Accountability Subcommittee on Health Care and Financial Services held a hearing yesterday titled “Inflation: A Preventable Crisis.” At the hearing, ...

WASHINGTON – Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) opened today’s subcommittee hearing examining how the Biden Administration’s reckless spending under the American Rescue Plan and the Inflation Reduction Act have driven inflation to 40-year highs.